Kevin J. Contrera
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Kevin J. Contrera has a total of 307 co-authors. Here are the top co-authors by number of shared publications:
Matthew E. Spector
Department of Otolaryngology University of Pittsburgh School of Medicine Pittsburgh Pennsylvania USA
12 shared publications- Shirley Y. Su
Department of Head and Neck Surgery MD Anderson Cancer Center Houston Texas USA
10 shared publications - Renata Ferrarotto
Department of Thoracic and Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
9 shared publications - Shaan Mohammed Raza
Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, Texas
9 shared publications - Dianna Roberts
Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas
8 shared publications - Ehab Y. Hanna
Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
8 shared publications
Latest Publications
- Open Access
- 6 November 2026
- Published by Elsevier in Cell Press Blue
Perioperative pembrolizumab in locally advanced cutaneous squamous cell carcinoma: A prospective phase 2 clinical trial
- 6 November 2026
- Published by Elsevier in Cell Press Blue
Open AccessPerioperative pembrolizumab in locally advanced cutaneous squamous cell carcinoma: A prospective phase 2 clinical trial
- Open Access
- 29 September 2026
- Published by Elsevier in Oral Oncology
- Vol. 182
The impact of regional lymph node depletion on response to anti-PD-1 therapy in recurrent and metastatic head and neck squamous cell carcinoma
- 29 September 2026
- Published by Elsevier in Oral Oncology
- Vol. 182
Open AccessThe impact of regional lymph node depletion on response to anti-PD-1 therapy in recurrent and metastatic head and neck squamous cell carcinoma
- Open Access
- 13 July 2026
- Published by Wiley in Laryngoscope Investigative Otolaryngology
- Vol. 11 (4)
Current Technical Skills Assessment Tools in Otolaryngology Residency: A Scoping Review
Objective: To review and synthesize the literature on technical skills assessment tools in otolaryngology residency programs. Data Sources: A comprehensive search of Medline, Embase, PubMed, and Google Scholar was performed from inception to January 2025. Review Methods: Following PRISMA guidelines, studies reporting on technical skills assessment tools in otolaryngology residency training were screened and abstracted independently in duplicate. Data were extracted on study characteristics, subspecialty, procedure type, training modality (simulation, cadaveric, operating room), assessment tool design, scoring scale, number of residents, and tool validity. Study quality was assessed using the Modified Educational Oxford Centre for Evidence‐Based Medicine framework. Results: Of 1270 screened studies, 146 met inclusion criteria, encompassing 3231 trainees across six otolaryngology subspecialties. Most studies were from the United States (59.6%), Canada (18.5%), and Denmark (10.3%). The largest subspecialty represented was otology and neurotology (42.5%), followed by rhinology and skull base surgery (21.2%), head and neck surgery (12.3%), general otolaryngology (11.6%), pediatric otolaryngology (7.5%), and laryngology (4.8%). Common assessment frameworks included Objective Structured Assessment of Technical Skills, Task‐Specific Checklists, and Global Rating Scales. Tools demonstrated construct, face, and content validity, with strong interrater reliability and sensitivity to training level. Innovations included automated performance analysis and 3D‐printed models. Conclusion: The synthesized list of procedures and their assessment tools can serve as a road map for otolaryngology residency programs. They support competency‐based medical education, differentiate skill levels, and guide feedback. Future work should focus on multicenter validation, standardization across programs, and integration of technology‐driven assessment methods to enhance surgical training outcomes.
- 13 July 2026
- Published by Wiley in Laryngoscope Investigative Otolaryngology
- Vol. 11 (4)
Open AccessCurrent Technical Skills Assessment Tools in Otolaryngology Residency: A Scoping Review
Objective: To review and synthesize the literature on technical skills assessment tools in otolaryngology residency programs. Data Sources: A comprehensive search of Medline, Embase, PubMed, and Google Scholar was performed from inception to January 2025. Review Methods: Following PRISMA guidelines, studies reporting on technical skills assessment tools in otolaryngology residency training were screened and abstracted independently in duplicate. Data were extracted on study characteristics, subspecialty, procedure type, training modality (simulation, cadaveric, operating room), assessment tool design, scoring scale, number of residents, and tool validity. Study quality was assessed using the Modified Educational Oxford Centre for Evidence‐Based Medicine framework. Results: Of 1270 screened studies, 146 met inclusion criteria, encompassing 3231 trainees across six otolaryngology subspecialties. Most studies were from the United States (59.6%), Canada (18.5%), and Denmark (10.3%). The largest subspecialty represented was otology and neurotology (42.5%), followed by rhinology and skull base surgery (21.2%), head and neck surgery (12.3%), general otolaryngology (11.6%), pediatric otolaryngology (7.5%), and laryngology (4.8%). Common assessment frameworks included Objective Structured Assessment of Technical Skills, Task‐Specific Checklists, and Global Rating Scales. Tools demonstrated construct, face, and content validity, with strong interrater reliability and sensitivity to training level. Innovations included automated performance analysis and 3D‐printed models. Conclusion: The synthesized list of procedures and their assessment tools can serve as a road map for otolaryngology residency programs. They support competency‐based medical education, differentiate skill levels, and guide feedback. Future work should focus on multicenter validation, standardization across programs, and integration of technology‐driven assessment methods to enhance surgical training outcomes.
- 8 July 2026
- Published by Elsevier in Oral Oncology
- Vol. 180, 108069
After hours: surgical end-time and postoperative complications in head and neck microvascular reconstruction
- 8 July 2026
- Published by Elsevier in Oral Oncology
- Vol. 180, 108069
After hours: surgical end-time and postoperative complications in head and neck microvascular reconstruction
- 2 July 2026
- Published by Elsevier in Oral Oncology
- Vol. 180, 108066
3D Volumetric-Based resection modeling to optimize reconstructive outcomes for ablative oral cavity defects
- 2 July 2026
- Published by Elsevier in Oral Oncology
- Vol. 180, 108066
3D Volumetric-Based resection modeling to optimize reconstructive outcomes for ablative oral cavity defects
- Open Access
- 2 July 2026
- Published by Wiley in Head & Neck
- Vol. 48 (12) , 3456-3468
Measurement Tools for Radiation‐Induced Fibrosis in Head and Neck Cancer: A Systematic Review
Background: Radiation‐induced fibrosis is a common, often debilitating late effect of head and neck cancer (HNC) treatment. An updated systematic review is needed to evaluate the reliability, validity, and clinical utility of fibrosis measurement tools. Methods: Cochrane Library, Medline, Embase.com , and Web of Science were systematically searched. Articles were independently screened by two reviewers using COSMIN checklists for risk of bias assessment, following PRISMA guidelines. Results: Of 4678 articles, 17 studies describing 13 tools met inclusion: six studies assessed four patient‐reported outcome measures, two assessed two clinician‐reported tools, and nine assessed seven imaging modalities. The Neck Fibrosis Scale, HN‐LEF Symptom Inventory, and LENT‐SOMA demonstrated validity and reliability. Young's modulus was the only imaging tool demonstrating both. Imaging studies had a higher risk of bias. Conclusion: Several subjective tools are reliable and valid for radiation‐induced fibrosis assessment in HNC. Young's modulus is the only objective imaging‐based tool that provides evidence of both validity and reliability, though methodological limitations remain.
- 2 July 2026
- Published by Wiley in Head & Neck
- Vol. 48 (12) , 3456-3468
Open AccessMeasurement Tools for Radiation‐Induced Fibrosis in Head and Neck Cancer: A Systematic Review
Background: Radiation‐induced fibrosis is a common, often debilitating late effect of head and neck cancer (HNC) treatment. An updated systematic review is needed to evaluate the reliability, validity, and clinical utility of fibrosis measurement tools. Methods: Cochrane Library, Medline, Embase.com , and Web of Science were systematically searched. Articles were independently screened by two reviewers using COSMIN checklists for risk of bias assessment, following PRISMA guidelines. Results: Of 4678 articles, 17 studies describing 13 tools met inclusion: six studies assessed four patient‐reported outcome measures, two assessed two clinician‐reported tools, and nine assessed seven imaging modalities. The Neck Fibrosis Scale, HN‐LEF Symptom Inventory, and LENT‐SOMA demonstrated validity and reliability. Young's modulus was the only imaging tool demonstrating both. Imaging studies had a higher risk of bias. Conclusion: Several subjective tools are reliable and valid for radiation‐induced fibrosis assessment in HNC. Young's modulus is the only objective imaging‐based tool that provides evidence of both validity and reliability, though methodological limitations remain.
- Open Access
- 29 June 2026
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 175 (3) , 650-656
Preoperative Neutrophil‐to‐Lymphocyte Ratio Predicts Recurrence in HPV‐Associated Oropharyngeal Cancer After Transoral Robotic Surgery
Objective: Evaluate the role of preoperative neutrophil‐to‐lymphocyte ratio (NLR) as a predictor of survival outcomes after transoral robotic surgery (TORS) for human papillomavirus‐related (HPV+) oropharyngeal squamous cell carcinoma (OPSCC). Study Design: Single‐institution retrospective review of patients who underwent TORS for HPV + OPSCC from April 2014 to October 2021 and had a preoperative complete blood count test. Setting: Tertiary academic center. Methods: Preoperative NLR was calculated from complete blood counts drawn within 1 month prior to surgery. Receiver operating characteristic curves evaluated performance of prognostic markers. Kaplan‐Meier estimator and Cox regression analyses were used to evaluate survival outcomes when controlling for confounding variables. Results: A total of 117 patients were included (85.5% male, 94.0% Caucasian, 59.6 ± 9.1 years old), of which 13 patients (11.1%) recurred at a median of 23.5 ± 23 months, including 7 distant metastases. At the latest follow‐up, 90.6% remained alive. On Kaplan‐Meier analyses, a preoperative NLR of >2.2 was associated with worse recurrence‐free survival (77.1% vs 95.5%, P = .02), whereas overall survival was similar between patients ( P = .94). When controlling for demographics, tumor stage, pathologic risk criteria, and adjuvant therapy, NLR > 2.2 remained a significant independent predictor of recurrence on multivariate Cox regression analysis (HR 20.6, 95% CI 1.92‐80.7, P = .012). Conclusion: While OS was similar across groups, a preoperative NLR of >2.2 predicted worse recurrence‐free survival in a cohort of patients with HPV + OPSCC who underwent TORS. Future studies may consider integrating NLR into prospective trials as a complementary risk‐stratification biomarker.
- 29 June 2026
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 175 (3) , 650-656
Open AccessPreoperative Neutrophil‐to‐Lymphocyte Ratio Predicts Recurrence in HPV‐Associated Oropharyngeal Cancer After Transoral Robotic Surgery
Objective: Evaluate the role of preoperative neutrophil‐to‐lymphocyte ratio (NLR) as a predictor of survival outcomes after transoral robotic surgery (TORS) for human papillomavirus‐related (HPV+) oropharyngeal squamous cell carcinoma (OPSCC). Study Design: Single‐institution retrospective review of patients who underwent TORS for HPV + OPSCC from April 2014 to October 2021 and had a preoperative complete blood count test. Setting: Tertiary academic center. Methods: Preoperative NLR was calculated from complete blood counts drawn within 1 month prior to surgery. Receiver operating characteristic curves evaluated performance of prognostic markers. Kaplan‐Meier estimator and Cox regression analyses were used to evaluate survival outcomes when controlling for confounding variables. Results: A total of 117 patients were included (85.5% male, 94.0% Caucasian, 59.6 ± 9.1 years old), of which 13 patients (11.1%) recurred at a median of 23.5 ± 23 months, including 7 distant metastases. At the latest follow‐up, 90.6% remained alive. On Kaplan‐Meier analyses, a preoperative NLR of >2.2 was associated with worse recurrence‐free survival (77.1% vs 95.5%, P = .02), whereas overall survival was similar between patients ( P = .94). When controlling for demographics, tumor stage, pathologic risk criteria, and adjuvant therapy, NLR > 2.2 remained a significant independent predictor of recurrence on multivariate Cox regression analysis (HR 20.6, 95% CI 1.92‐80.7, P = .012). Conclusion: While OS was similar across groups, a preoperative NLR of >2.2 predicted worse recurrence‐free survival in a cohort of patients with HPV + OPSCC who underwent TORS. Future studies may consider integrating NLR into prospective trials as a complementary risk‐stratification biomarker.
- Open Access
- 11 June 2026
- Published by MDPI AG in Lymphatics
- Vol. 4 (2) , 30
A Narrative Review of Lymphedema Following Head and Neck Cancer Treatment
Head and neck lymphedema (HNL) is a common complication of head and neck cancer (HNC) treatment. Surgery and radiation, the backbones of HNC treatment, disrupt lymphatic networks through direct injury and fibrosis, leading to accumulation of lymphatic fluid in interstitial spaces. This causes swelling of external and internal structures, leading to decreased quality of life, cosmetic distress, social withdrawal, and functional deficits such as dysphagia, dysphonia, and reduced cervical mobility. In this narrative review, we provide a broad overview of the pathophysiology, assessment, and prevention of HNL. Key surgical factors include the extent of neck dissection, including specific levels removed. Radiation compounds surgical injury through lymphatic fibrosis in a dose-dependent manner. Emerging radiation de-escalation strategies may reduce HNL, though lymphedema is rarely studied as a trial endpoint. Moreover, assessment of HNL remains challenging due to the absence of a gold standard—patient-reported outcome measures, clinician-reported scales, and instrumental tests each capture distinct components of external and internal HNL. Currently, the cornerstone of HNL treatment is conservative management with complete decongestive therapy, which shows mixed efficacy and does not address internal HNL. Surgical options including lymphovenous anastomosis and vascularized lymph node transfer show early promise but remain limited to case reports and small series. Lymphatic imaging, particularly indocyanine green lymphography, represents a promising emerging modality for guiding personalized treatment planning, though application to the head and neck remains challenging. Ultimately, current management of HNL remains largely reactive, with a noticeable lack of preventative therapies. Future research may benefit from better defining surgical options, including HNL as an endpoint in radiation de-escalation trials, and validate emerging lymphatic imaging techniques in order to improve outcomes for HNC survivors.
- 11 June 2026
- Published by MDPI AG in Lymphatics
- Vol. 4 (2) , 30
Open AccessA Narrative Review of Lymphedema Following Head and Neck Cancer Treatment
Head and neck lymphedema (HNL) is a common complication of head and neck cancer (HNC) treatment. Surgery and radiation, the backbones of HNC treatment, disrupt lymphatic networks through direct injury and fibrosis, leading to accumulation of lymphatic fluid in interstitial spaces. This causes swelling of external and internal structures, leading to decreased quality of life, cosmetic distress, social withdrawal, and functional deficits such as dysphagia, dysphonia, and reduced cervical mobility. In this narrative review, we provide a broad overview of the pathophysiology, assessment, and prevention of HNL. Key surgical factors include the extent of neck dissection, including specific levels removed. Radiation compounds surgical injury through lymphatic fibrosis in a dose-dependent manner. Emerging radiation de-escalation strategies may reduce HNL, though lymphedema is rarely studied as a trial endpoint. Moreover, assessment of HNL remains challenging due to the absence of a gold standard—patient-reported outcome measures, clinician-reported scales, and instrumental tests each capture distinct components of external and internal HNL. Currently, the cornerstone of HNL treatment is conservative management with complete decongestive therapy, which shows mixed efficacy and does not address internal HNL. Surgical options including lymphovenous anastomosis and vascularized lymph node transfer show early promise but remain limited to case reports and small series. Lymphatic imaging, particularly indocyanine green lymphography, represents a promising emerging modality for guiding personalized treatment planning, though application to the head and neck remains challenging. Ultimately, current management of HNL remains largely reactive, with a noticeable lack of preventative therapies. Future research may benefit from better defining surgical options, including HNL as an endpoint in radiation de-escalation trials, and validate emerging lymphatic imaging techniques in order to improve outcomes for HNC survivors.
- Open Access
- 1 May 2026
- Published by MDPI AG in Preprints.org
A Narrative Review of Lymphedema Following Head and Neck Cancer Treatment
Head and neck lymphedema (HNL) is a common complication of head and neck cancer (HNC) treatment, with upwards of 70-90% of patients suffering from this condition. Surgery and radiation, the backbones of HNC treatment, disrupt lymphatic networks through direct injury and fibrosis, leading to accumulation of lymphatic fluid in interstitial spaces. This causes swelling of external and internal structures, leading to decreased quality of life, cosmetic distress, social withdrawal, and functional deficits such as dys-phagia, dysphonia, and reduced cervical mobility. Having a reliable assessment tool is key to diagnosing and monitoring HNL; however, few tools specific to HNL exist. Cur-rently, the cornerstone of HNL treatment is conservative management with complete decongestive therapy, which shows mixed efficacy. There is a lack of surgical options as well as prophylactic interventions. Imaging of lymphatic channels is a promising mo-dality that can help providers guide and plan personalized therapies. This paper provides a narrative review of the pathophysiology, assessment, and prevention of HNL, high-lighting future directions for improvement.
- 1 May 2026
- Published by MDPI AG in Preprints.org
Open AccessA Narrative Review of Lymphedema Following Head and Neck Cancer Treatment
Head and neck lymphedema (HNL) is a common complication of head and neck cancer (HNC) treatment, with upwards of 70-90% of patients suffering from this condition. Surgery and radiation, the backbones of HNC treatment, disrupt lymphatic networks through direct injury and fibrosis, leading to accumulation of lymphatic fluid in interstitial spaces. This causes swelling of external and internal structures, leading to decreased quality of life, cosmetic distress, social withdrawal, and functional deficits such as dys-phagia, dysphonia, and reduced cervical mobility. Having a reliable assessment tool is key to diagnosing and monitoring HNL; however, few tools specific to HNL exist. Cur-rently, the cornerstone of HNL treatment is conservative management with complete decongestive therapy, which shows mixed efficacy. There is a lack of surgical options as well as prophylactic interventions. Imaging of lymphatic channels is a promising mo-dality that can help providers guide and plan personalized therapies. This paper provides a narrative review of the pathophysiology, assessment, and prevention of HNL, high-lighting future directions for improvement.